In December 2025, Farmak International’s Spanish manufacturing site, ICM Farmak, obtained a European Union Good Manufacturing Practice (EU GMP) certificate. The inspection was conducted by the Spanish Agency of Medicines and Medical Devices (AEMPS), operating under the Spanish Ministry of Health.
The certificate confirms the facility’s compliance with EU GMP requirements for the manufacturing of sterile medicinal products, including injectable medicines in vials.
The Spanish plant is equipped with state-of-the-art aseptic production lines for medicinal products in vials and pre-filled syringes, as well as dedicated R&D and quality control laboratories.
The facility specializes in the production of sterile injectable medicines used in the treatment of patients in intensive care, anesthesiology, cardiology, endocrinology, obstetrics and gynecology, psychiatry, as well as oncology and immunology.
Farmak Group supplies medicinal products to more than 60 countries worldwide. The manufacturing site in Spain is aimed at further expanding the Group’s production capacities and supporting its international presence, with a focus on the markets of Europe, Asia, the Middle East, and the Americas.
Farmak International is responsible for the global operational activities of the Farmak Group, management of international assets, and business development in external markets.
